Vlot MC - Search Results

1

F18-Choline PET/CT: a novel tool to localize parathyroid adenoma?

van Raalte DH, Vlot MC, Zwijnenburg A, ten Kate RW. van Raalte DH, et al. Among authors: vlot mc. Clin Endocrinol (Oxf). 2015 Jun;82(6):910-2. doi: 10.1111/cen.12681. Epub 2015 Jan 15. Clin Endocrinol (Oxf). 2015. PMID: 25410059 No abstract available.

2

Peripheral Insulin Extraction in Non-Diabetic Subjects and Type 2 Diabetes Mellitus Patients.

van Raalte DH, van der Palen E, Idema P, Wong L, Keet SWM, Vlot M, Tukkie R, van Vlies B, Serné EH, Ten Kate RW. van Raalte DH, et al. Exp Clin Endocrinol Diabetes. 2020 Aug;128(8):520-527. doi: 10.1055/a-0808-4029. Epub 2018 Dec 17. Exp Clin Endocrinol Diabetes. 2020. PMID: 30557891

3

Plasma FGF23 is not elevated in prostate cancer.

Vlot MC, Bijnsdorp I, den Heijer M, de Jonge R, van Moorselaar RJA, Heijboer AC. Vlot MC, et al. Clin Chim Acta. 2018 Mar;478:129-131. doi: 10.1016/j.cca.2017.12.035. Epub 2017 Dec 23. Clin Chim Acta. 2018. PMID: 29277536 No abstract available.

4

A surprising cause of reversible dilated cardiomyopathy.

Vlot M, de Jong M, de Ronde P, Tukkie R. Vlot M, et al. BMJ Case Rep. 2014 May 30;2014:bcr2013203512. doi: 10.1136/bcr-2013-203512. BMJ Case Rep. 2014. PMID: 24879729 Free PMC article.

5

The relationship between serum IGF-1, handgrip strength, physical performance and falls in elderly men and women.

van Nieuwpoort IC, Vlot MC, Schaap LA, Lips P, Drent ML. van Nieuwpoort IC, et al. Among authors: vlot mc. Eur J Endocrinol. 2018 Aug;179(2):73-84. doi: 10.1530/EJE-18-0076. Epub 2018 May 22. Eur J Endocrinol. 2018. PMID: 29789408

6

Clinical utility of bone markers in various diseases.

Vlot MC, den Heijer M, de Jongh RT, Vervloet MG, Lems WF, de Jonge R, Obermayer-Pietsch B, Heijboer AC. Vlot MC, et al. Bone. 2018 Sep;114:215-225. doi: 10.1016/j.bone.2018.06.011. Epub 2018 Jun 18. Bone. 2018. PMID: 29920402 Review.

7

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)₂D, but No Difference in Ratio of 25(OH)D/24,25(OH)₂D and FGF23 Concentrations.

Vlot MC, Boekel L, Kragt J, Killestein J, van Amerongen BM, de Jonge R, den Heijer M, Heijboer AC. Vlot MC, et al. Nutrients. 2019 Nov 15;11(11):2774. doi: 10.3390/nu11112774. Nutrients. 2019. PMID: 31731605 Free PMC article.

8

Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.

Vlot MC, Klink DT, den Heijer M, Blankenstein MA, Rotteveel J, Heijboer AC. Vlot MC, et al. Bone. 2017 Feb;95:11-19. doi: 10.1016/j.bone.2016.11.008. Epub 2016 Nov 11. Bone. 2017. PMID: 27845262 Clinical Trial.

9

Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection.

Vlot MC, Grijsen ML, Prins JM, de Jongh RT, de Jonge R, den Heijer M, Heijboer AC. Vlot MC, et al. PLoS One. 2018 Mar 9;13(3):e0193679. doi: 10.1371/journal.pone.0193679. eCollection 2018. PLoS One. 2018. PMID: 29522570 Free PMC article.

10

Gender-Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen.

Vlot MC, Wiepjes CM, de Jongh RT, T'Sjoen G, Heijboer AC, den Heijer M. Vlot MC, et al. J Bone Miner Res. 2019 Oct;34(10):1862-1872. doi: 10.1002/jbmr.3762. Epub 2019 Aug 19. J Bone Miner Res. 2019. PMID: 31099910 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters